Compare · AYTU vs HRMY

AYTU vs HRMY

Side-by-side comparison of Aytu BioPharma Inc. (AYTU) and Harmony Biosciences Holdings Inc. (HRMY): market cap, price performance, sector, and recent activity on the wire.

Summary

  • Both AYTU and HRMY operate in Biotechnology: Pharmaceutical Preparations (Health Care), so they compete in similar markets.
  • HRMY is the larger of the two at $1.94B, about 97.9x AYTU ($19.8M).
  • Over the past year, AYTU is down 10.9% and HRMY is down 2.9% - HRMY leads by 8.0 points.
  • AYTU has been more active in the news (11 items in the past 4 weeks vs 5 for HRMY).
  • HRMY has more recent analyst coverage (25 ratings vs 3 for AYTU).
PerformanceAYTU-10.95%HRMY-2.94%
2025-11-17+0.00%2026-11-16
MetricAYTUHRMY
Company
Aytu BioPharma Inc.
Harmony Biosciences Holdings Inc.
Price
-
-
Market cap
$19.8M
$1.94B
1M return
-10.95%
-13.06%
1Y return
-10.95%
-2.94%
Industry
Biotechnology: Pharmaceutical Preparations
Biotechnology: Pharmaceutical Preparations
Exchange
NASDAQ
NASDAQ
IPO
2020
News (4w)
11
5
Recent ratings
3
25
AYTU

Aytu BioPharma Inc.

Aytu Biopharma, Inc., a specialty pharmaceutical company, focuses on developing and commercializing novel therapeutics and consumer healthcare products the United States and internationally. The company offers Adzenys XR-ODT for the treatment of attention deficit hyperactivity disorder (ADHD) in patients from 6 years and older; Cotempla XR-ODT for the treatment of ADHD in patients from 6 to 17 years old; and Adzenys ER, an oral suspension for the treatment of ADHD in patients from 6 years and older. It also provides Karbinal ER, a carbinoxamine oral suspension for the treatment of seasonal and perennial allergies; Poly-Vi-Flor and Tri-Vi-Flor prescription supplements for infants and children for the treatment of fluoride deficiency; Tuzistra XR, a prescription antitussive consisting of codeine polistirex and chlorpheniramine polistirex in an oral suspension; and ZolpiMist, an oral spray for the treatment of insomnia. The company was formerly known as Aytu BioScience, Inc. and changed its name to Aytu Biopharma, Inc. in March 2021. Aytu Biopharma, Inc. was incorporated in 2015 and is headquartered in Englewood, Colorado.

HRMY

Harmony Biosciences Holdings Inc.

Harmony Biosciences Holdings, Inc., a commercial-stage pharmaceutical company, develops and commercializes therapies for patients with rare neurological disorders. Its product, WAKIX is a medication for the treatment of excessive daytime sleepiness in adult patients with narcolepsy in the United States. The company was formerly known as Harmony Biosciences II, Inc. and changed its name to Harmony Biosciences Holdings, Inc. in February 2020. Harmony Biosciences Holdings, Inc. was incorporated in 2017 and is based in Plymouth Meeting, Pennsylvania.

Latest AYTU

Latest HRMY